Katherine Johansen Taber PhD

Katherine (Katie) Johansen Taber, Ph.D. is Director of the American Medical Association’s Personalized Medicine program, which focuses on educating physicians about the clinical implementation of genetics and on identifying and managing genetics policy issues affecting health care providers. She also advises the AMA Board of Trustees and the House of Delegates on genetics issues such as the oversight of genetic testing, gene patenting, stem cell research, and newborn screening.

Katie is a member of the Institute of Medicine’s Roundtable on Translating Genomic-based Research for Health, the VA National Research Advisory Council, the El Camino Hospital Genomic Medicine Institute Advisory Council, and a number of other genetics-focused workgroups. She serves as the Assistant Secretary for the AMA’s Council on Science and Public Health and also represents the AMA as a Dissemination and Implementation Partner for the United States Preventive Services Task Force. Katie earned her Ph.D. in Molecular, Cell, and Developmental Biology at the University of California, Los Angeles, and conducted post-doctoral research at the USDA. She has held teaching appointments at UCLA, California State Polytechnic University, University of Idaho, and Columbia College Chicago.